| 04/23/2026 8:25 PM | Kirwin Patrick D. (1927062) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/09/2026 3:01 PM | Promis Neurosciences (1374339) Filer | Form DEF 14A | |
| 04/09/2026 3:02 PM | Promis Neurosciences (1374339) Filer | Form DEFA14A | |
| 04/09/2026 3:03 PM | Promis Neurosciences (1374339) Filer | Form ARS | |
| 04/07/2026 3:27 PM | JANUS HENDERSON GROUP PLC (1274173) Filed by Promis Neurosciences (1374339) Subject | Form SCHEDULE 13G | |
| 04/02/2026 11:15 PM | Promis Neurosciences (1374339) Filer | Form EFFECT | |
| 03/26/2026 11:15 PM | Promis Neurosciences (1374339) Filer | Form EFFECT | |
| 03/25/2026 4:22 PM | Promis Neurosciences (1374339) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 03/25/2026 3:34 PM | Promis Neurosciences (1374339) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/25/2026 7:06 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/18/2026 11:26 AM | Promis Neurosciences (1374339) Subject Wellington Biomedical Innovation Master Investors (0) Cayman | Form SCHEDULE 13G | |
Get the Latest News and Ratings for PMN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Promis Neurosciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/06/2026 6:28 AM | Promis Neurosciences (1374339) Issuer Williams Eugene (1927626) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/04/2026 5:08 PM | Promis Neurosciences (1374339) Issuer Williams Eugene (1927626) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 6:30 PM | ABG Global Life Science Capital Partners V GP Ltd (2080887) Reporting ABG Global Life Science Capital Partners V GP, L.P. (2080886) Reporting ABG V-SIV IX Ltd (2113290) Reporting ABG V-SIV X Ltd (2113291) Reporting Ally Bridge Group Global Life Science Capital Partners V, L.P. (1951727) Reporting Promis Neurosciences (1374339) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/23/2026 7:31 AM | Kaplan Johanne (1967717) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/17/2026 8:36 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Promis Neurosciences (1374339) Subject | Form SCHEDULE 13G/A | |
| 02/05/2026 7:39 PM | Promis Neurosciences (1374339) Issuer Warma Neil K (1437911) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 7:40 PM | Kaplan Johanne (1967717) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 7:41 PM | Cashman Neil (1927064) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 7:36 PM | Kirwin Patrick D. (1927062) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 7:37 PM | Milbury Max A. (1927056) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:00 PM | ABG Management Ltd. (1832106) Reporting Alex Slanix Paul (2092283) Reporting Ally Bridge Group (0) NY Ally Bridge MedAlpha Master Fund L.P. (1831963) Reporting Promis Neurosciences (1374339) Issuer Yu Fan (1668029) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/05/2026 6:02 PM | ABG Management Ltd. (1832106) Filed by Promis Neurosciences (1374339) Subject | Form SCHEDULE 13D/A | |
| 01/30/2026 7:25 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/16/2025 3:48 PM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/24/2025 7:30 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/19/2025 8:25 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 5:26 PM | ARMISTICE CAPITAL, LLC (1601086) Filed by Promis Neurosciences (1374339) Subject | Form SCHEDULE 13G/A | |
| 11/14/2025 1:12 PM | GREAT POINT PARTNERS LLC (1281446) Filed by Promis Neurosciences (1374339) Subject | Form SCHEDULE 13G/A | |
| 11/12/2025 6:05 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 6:06 AM | Promis Neurosciences (1374339) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/29/2025 3:30 PM | ABG Management Ltd. (1832106) Filed by Promis Neurosciences (1374339) Subject | Form SCHEDULE 13D | |
| 10/24/2025 3:30 PM | Alex Slanix Paul (2092283) Reporting Promis Neurosciences (1374339) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 10/24/2025 3:34 PM | ABG Management Ltd. (1832106) Reporting Alex Slanix Paul (2092283) Reporting Ally Bridge Group (0) NY Ally Bridge MedAlpha Master Fund L.P. (1831963) Reporting Promis Neurosciences (1374339) Issuer Yu Fan (1668029) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 3:10 PM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/23/2025 5:02 AM | Promis Neurosciences (1374339) Subject SPHERA FUNDS MANAGEMENT LTD. (1496201) Filed by | Form SCHEDULE 13G/A | |
| 10/15/2025 4:24 PM | Promis Neurosciences (1374339) Subject Sclar Jeremy M. (1955608) Filed by | Form SCHEDULE 13G/A | |
| 10/06/2025 8:12 AM | Milbury Max A. (1927056) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/30/2025 3:15 PM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2025 3:15 PM | Jeremy M. Sclar 2012 Irrevocable Family Trust (2089163) Reporting Promis Neurosciences (1374339) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 09/30/2025 3:17 PM | Jeremy M. Sclar 2012 Irrevocable Family Trust (2089163) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
|
| 09/24/2025 7:58 AM | Promis Neurosciences (1374339) Issuer Warma Neil K (1437911) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 7:45 AM | ALTSTIEL LARRY DOUGLAS (1619444) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 7:48 AM | Kaplan Johanne (1967717) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 7:51 AM | Cashman Neil (1927064) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 7:54 AM | Milbury Max A. (1927056) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 4:14 PM | Promis Neurosciences (1374339) Filer | Form PRE 14A | |
| 09/10/2025 11:15 PM | Promis Neurosciences (1374339) Filer | Form EFFECT | |
| 09/04/2025 3:30 PM | Promis Neurosciences (1374339) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 09/03/2025 6:05 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/24/2025 11:15 PM | Promis Neurosciences (1374339) Filer | Form EFFECT | |
| 08/14/2025 3:15 PM | GORDON MICHAEL S (1034608) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 6:05 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2025 6:10 AM | Promis Neurosciences (1374339) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/04/2025 4:49 PM | ABG Management Ltd. (1832106) Reporting Ally Bridge Group (0) NY Ally Bridge MedAlpha Master Fund L.P. (1831963) Reporting Promis Neurosciences (1374339) Issuer Yu Fan (1668029) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/04/2025 4:55 PM | ABG Management Ltd. (1832106) Filed by Promis Neurosciences (1374339) Subject | Form SCHEDULE 13G | |
| 07/31/2025 8:36 PM | Promis Neurosciences (1374339) Subject Shaf QIC LLC (2038058) Filed by | Form SCHEDULE 13G/A | |
| 07/29/2025 7:18 PM | Promis Neurosciences (1374339) Issuer Title 19 Promis (2005531) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/29/2025 7:20 PM | GORDON MICHAEL S (1034608) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/28/2025 6:15 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/22/2025 5:30 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2025 4:04 PM | Promis Neurosciences (1374339) Issuer Shafmaster Madge K. (1927066) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 4:11 PM | Kirwin Patrick D. (1927062) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 4:23 PM | Mandel-Brehm Josh (1927058) Reporting Promis Neurosciences (1374339) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 3:45 PM | Promis Neurosciences (1374339) Issuer Williams Eugene (1927626) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/13/2025 7:00 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/12/2025 6:37 AM | Promis Neurosciences (1374339) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/12/2025 6:39 AM | Promis Neurosciences (1374339) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |